Similar findings were obtained in vivo using DSS-induced colitis mice model, where treating these mice with exogenous furin relieved DSS-induced colitis, a mechanism involving the activation of Nrf2 and the upregulation of GPX4. The gene discussed is FURIN; the disease is colitis.